Oduk et al. (2018) [32] demonstrated that nanoparticle-mediated delivery even increases the angiogenic and therapeutic potency of vascular endothelial growth factor for the treatment of ischemic heart disease [32]. The gene discussed is VEGFA; the disease is coronary artery disorder.